Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disruption of the DNA double helix structure through chemical crosslinking at the N7 position of guanine bases. This modification is induced by alkylating agents, leading to interference with DNA replication and repair, ultimately triggering apoptosis, especially in rapidly dividing cells. Many chemotherapeutic agents exploit this vulnerability to selectively kill cancer cells.
Induction of DNA crosslinks at guanine N7 positions, leading to replication blockage, impaired repair, and apoptosis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Double Helix Structure Integrity Disruption by Crosslinking at N7 Guanine Positions (N/A).